Bavarian Nordic announces commercial launch of mpox vaccine

News brief
Topics
Mpox

Bavarian Nordic today announced the commercial launch of its vaccine against mpox and smallpox, which means the vaccine will now be available outside of designated clinics that were tapped to administer doses from the US government's vaccine supply.

vaccine bandaid
DMEPhotography/iStock

US mpox activity on the rise

The development comes as US mpox cases are outpacing activity reported last year at this time. So far 576 cases have been reported this year as of the week ending March 23, according to data from the US Centers for Disease Control and Prevention (CDC). Last year at this time, 298 cases were reported.

The commercial launch of the product, called Jynneos, will allow patients to get the vaccine at more locations, including clinics and pharmacies. Last October, federal health officials recommended the vaccine for routine use adults at risk for mpox infection.

Considerations for uninsured and underinsured

In webpage updates yesterday ahead of the commercial vaccine rollout, the CDC said it is working with Bavarian Nordic to ensure that people will continue to have broad access to the vaccine, including those who are underinsured and uninsured.

Bavarian Nordic said in a press release today that though mpox is no longer a public health emergency, the United States still averages about 200 cases a month, with transmission still occurring across most states. It said CDC data suggests that of 2 million people eligible to receive Jynneos, 60% remain unvaccinated.

Paul Chapin, the company's president and chief executive officer, said, "We look forward to working with healthcare providers across the nation to increase awareness and availability of the mpox vaccine."

Alaskapox virus renamed as borealpox virus

News brief
Topics
Misc Emerging Topics

The Alaska Department of Health (ADH) announced that it has been consulting with the US Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) to change the name of the Alaskapox virus to “borealpox virus,” with the renaming taking effect with the start of April.

pox lesion
Rahman Ali / iStock

ADH said the name references the ecosystem where the virus was found in humans and small animal reservoirs. Also, it said the name is less specific and offers more leeway for the possibility of the virus being identified in animals and humans outside of Alaska.

Virus naming has shifted away from specific locations

Virus naming has sometimes been a hot button issue, and over the past several years, naming has shifted away from nomenclature that includes specific geographic locations or populations.

Earlier this year, the state reported the seventh known case of borealpox—a man from the Kenai Peninsula. His infection marked the first fatality from the novel orthopox virus. The case was notable, partly because it was the first to occur outside of the Fairbanks area, suggesting that the virus may be more widespread in the state's small mammals than previously known.

This week's top reads

  1. DR Congo probes outbreak of deadly, mysterious flu-like illness

    The main symptoms are fever, headache, runny nose, breathing problems, and anemia.

    Stephanie Soucheray

  2. Lab results expected soon in DR Congo's mystery outbreak

    Children younger than 5 years are the most affected group and account for the largest portion of deaths.

    Lisa Schnirring
    African girl doctor check

  3. Initial samples in DR Congo unexplained outbreak positive for malaria

    Of 12 samples, 10 were malaria-positive, but officials continue to investigate other contributing factors.

    Lisa Schnirring
    malaria infected rbc

  4. Officials continue probe on DR Congo mystery illness

    31 people have died and 406 people have been sickened by the illness, which causes fever, headache, cough, runny nose, and body aches.

    Stephanie Soucheray
    dec health

  5. WHO deploys expert team to DR Congo to assist with undiagnosed outbreak probe

    As DRC officials await test results, WHO experts are also bringing medicine and test equipment to help local responders.

    Lisa Schnirring
    PCR test

  6. China reports two more H9N2 avian flu cases

    H9N2 is known to circulate in poultry in the region, and infections are typically reported in children who experience mild disease.

    Lisa Schnirring

  7. Arizona confirms 2 avian flu infections as California probes second potential case in a child

    Arizona's patients were exposed to sick poultry at a large commercial farm in Pinal County.

    Lisa Schnirring
    layer farm worker

  8. Pediatric RSV vaccine trials on hold, FDA says

    The FDA says the hold is related to concerns about safety findings from a now-paused clinical trial of two RSV vaccine candidates in infants.

    Chris Dall
    Infant with RSV in hospital

  9. Almost a third of preteens, teens with long COVID still not recovered at 2 years, study shows

    Those who reported COVID reinfections during the study period had the most symptoms through 24 months. 

    Stephanie Soucheray
    teen with long covid

  10. Ferret study suggests connection between H5N1 shedding in air and transmissibility

    The authors say it's crucial to better understand how the virus is spreading, amid the ongoing risk of exposure to farm workers and transmission among animal species.

    Lisa Schnirring